These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1115851)

  • 41. In vitro study of erythropoiesis in patients with aplastic anemia and myelodysplastic syndromes: a possible tool for prospective determination of the clinical effectiveness of growth factors.
    Aoki A; Shibata A
    Hematol Pathol; 1992; 6(3):143-53. PubMed ID: 1429342
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Regulatory mechanisms of erythropoiesis in vitro].
    Gaciong Z; Górski A
    Postepy Hig Med Dosw; 1980; 34(2):143-67. PubMed ID: 7017640
    [No Abstract]   [Full Text] [Related]  

  • 43. Changes in histone acetylation and RNA synthesis in the spleen of polycythemic mouse after erythropoietin injection.
    Takaku F; Nakao K; Ono T; Terayama H
    Biochim Biophys Acta; 1969 Dec; 195(2):396-400. PubMed ID: 5366928
    [No Abstract]   [Full Text] [Related]  

  • 44. Partial purification procedure for human urinary erythropoietin by preparative isotachophoresis.
    Puschmann M; Thorn W; Yen Y
    Res Exp Med (Berl); 1978 Sep; 173(3):293-6. PubMed ID: 725329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Erythropoietin and the inhibitor of erythropoiesis in the amniotic fluid during the first trimester of normal human pregnancy.
    Lazewska M
    Acta Physiol Pol; 1981; 32(3):327-32. PubMed ID: 7304201
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A complement independent erythropoietic inhibitor acting on the progenitor cell in refractory anemia.
    Browman GP; Freedman MH; Blajchman MA; McBride JA
    Am J Med; 1976 Oct; 61(4):572-8. PubMed ID: 973651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinico-hematological studies on the activity of serum erythropoietin and erythropoiesis in hypoplastic anemia].
    Kashiwagi S
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):533-45. PubMed ID: 3758917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ABILITY OF TAMARINS TO PRODUCE AND RESPOND TO ERYTHROPOIETIN.
    MIRAND EA; PRENTICE TC; GRACE JT
    Nature; 1964 Dec; 204():1064-6. PubMed ID: 14243383
    [No Abstract]   [Full Text] [Related]  

  • 49. Erythrokinetics in the treatment of aplastic anemia with methandrostenolone.
    Reynafarje C; Faura J
    Arch Intern Med; 1967 Dec; 120(6):654-60. PubMed ID: 6058400
    [No Abstract]   [Full Text] [Related]  

  • 50. In vitro bioassay of erythropoietic activity in serum using mouse spleen cells. The effect of heat inactivation on serum erythropoietin.
    Elder GE; Shannon JS; Lappin TR; Taylor T; Bridges JM
    Blood Cells; 1986; 11(3):409-19. PubMed ID: 3742058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies on the genesis of anemia in chronic myeloid leukaemia--in vitro response of bone marrow cells to erythropoietin.
    Lucarelli G; Porcellini A; Tomasucci M
    Haematologica; 1972 Apr; 57(11):708-16. PubMed ID: 4200305
    [No Abstract]   [Full Text] [Related]  

  • 52. Hemopoiesis in pituitary dwarfs treated with human growth hormone and testosterone.
    Jepson JH; McGarry EE
    Blood; 1972 Feb; 39(2):229-48. PubMed ID: 5009028
    [No Abstract]   [Full Text] [Related]  

  • 53. Humoral control of hemopoiesis.
    Gordon AS; Zanjani ED
    Adv Intern Med; 1972; 18():39-58. PubMed ID: 4124022
    [No Abstract]   [Full Text] [Related]  

  • 54. [Changes of erythropoietin and erythropoietin-responsive cells in cases of aplastic anemia reacting to anabolic steroids].
    Shirokura T; Shiroki M; Suda E; Yatagai J; Yoshimatsu H
    Horumon To Rinsho; 1977 Dec; 25(12):1363-9. PubMed ID: 598045
    [No Abstract]   [Full Text] [Related]  

  • 55. A protein inhibitor of erythropoiesis.
    Lewis JP; Neal WA; Moores RR; Gardner E; Alford DA; Smith LL; Wright CS; Welch ET
    J Lab Clin Med; 1969 Oct; 74(4):608-13. PubMed ID: 5821517
    [No Abstract]   [Full Text] [Related]  

  • 56. Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor.
    Divoky V; Song J; Horvathova M; Kralova B; Votavova H; Prchal JT; Yoon D
    J Mol Med (Berl); 2016 May; 94(5):597-608. PubMed ID: 26706855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. STUDIES OF PLASMA FE59 DISAPPEARANCE--A MANIFESTATION OF INEFFECTIVE ERYTHROPOIESIS AND OF HEMOLYSIS.
    GEVIRTZ NR; WASSERMAN LR; SHARNEY L; TENDLER D
    Blood; 1965 Jun; 25():976-89. PubMed ID: 14294773
    [No Abstract]   [Full Text] [Related]  

  • 58. Diamond-Blackfan syndrome: lymphocyte-mediated suppression of erythropoiesis.
    Hoffman R; Zanjani ED; Vila J; Zalusky R; Lutton JD; Wasserman LR
    Science; 1976 Sep; 193(4256):899-900. PubMed ID: 986086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Separation of an inhibitor of erythropoiesis in "middle molecules" from hemodialysate from patients with chronic renal failure.
    Saito A; Suzuki I; Chung TG; Okamoto T; Hotta T
    Clin Chem; 1986 Oct; 32(10):1938-41. PubMed ID: 3757214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Excessive iron state in impaired erythropoiesis.
    Miyazaki T
    Nihon Ketsueki Gakkai Zasshi; 1978 Dec; 41(6):1339-44. PubMed ID: 751416
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.